4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000111
Chief Medical Officer sold 3,705 shares at $43.85 ($162,464)
- Chief Medical Officer acquired 8,375 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,375 | 47,441 | D | ||
| 2024-07-01 | Sale : show line 2 in the form 10b5-1 | −3,705 | $43.85 | $162,464 | 43,736 | D |
| Open-market sales · 3,705 sh · avg $43.85 · $162,464 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-01 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −8,375 | 16,749 | D |
Loading xslF345X05/wk-form4_1720038596.xml…